NHS: Dividend Isn't Supported By Earnings
2026-01-18 20:10:49 ET
Overview
While market indices continue to hover near all-time highs, it can be difficult to find an attractively valued opportunity in the market. However, many income funds still trade at reasonable valuations given the uncertainty of the debt markets. Neuberger High Yield Strategies ( NHS ) trades at a small discount to NAV and provides exposure to a diverse portfolio of income-generating assets. When I previously covered NHS, I issued a hold rating due to the fund's vulnerability to high interest rates. Since my last coverage, the fund has released an updated annual report, so I wanted to reassess the current value proposition now that we've crossed into the new year....
Read the full article on Seeking Alpha
For further details see:
NHS: Dividend Isn't Supported By EarningsNASDAQ: NHS
NHS Trading
-0.19% G/L:
$7.705 Last:
123,480 Volume:
$7.73 Open:


